Literature DB >> 18706200

Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance.

Xiang-yu Chen1, Jian-sheng Li, Qian-ping Liang, De-zhi He, Jing Zhao.   

Abstract

BACKGROUND: Esophageal carcinoma is a common kind of malignant tumor and about 90% of which is esophageal squamous cell carcinoma (ESCC), and it has a high incidence in China. In recent years it has been argued that angiogenesis plays a key role in tumor growth and metastasis and it is a complex process influenced by many factors. This study was aimed to investigate the expression of PC cell-derived growth factor (PCDGF or progranulin) and vascular endothelial growth factor (VEGF) in ESCC tissue and their relationship with clinical pathological parameters of ESCC, clarify the role of PCDGF and VEGF in the angiogenesis of ESCC.
METHODS: The expression of PCDGF and VEGF in 50 surgical specimens from patients with ESCC and 20 with normal esophageal mucosa were detected by immunohistochemistry. The vascular endothelial cells in tumor tissues were labeled by antibody to CD105 for counting microvessel density (MVD).
RESULTS: The expression of PCDGF and VEGF in ESCC was significantly higher than that in normal mucosa. Expression correlated with the depth of tumor invasion, lymph node metastasis, and TNM (classification tumor, nodes, metastasis). In ESCC, both the expression level of PCDGF and VEGF had a positive correlation with MVD and the expression of PCDGF had a significant correlation with the expression of VEGF.
CONCLUSIONS: These results show that both of PCDGF and VEGE have higher expression in ESCC, which indicate that they have a close relationship with angiogenesis. They may be involved in tumor growth, infiltration and metastasis through promoting tumor angiogenesis and may be an important index reflecting biological behavior and prognosis of ESCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706200

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  13 in total

1.  Progranulin overexpression predicts overall survival in patients with glioblastoma.

Authors:  Minqing Wang; Gang Li; Junyi Yin; Tao Lin; Jian Zhang
Journal:  Med Oncol       Date:  2011-12-13       Impact factor: 3.064

Review 2.  Progranulin: a growth factor, a novel TNFR ligand and a drug target.

Authors:  Chuan-ju Liu; Xavier Bosch
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

Review 3.  Cellular effects of progranulin in health and disease.

Authors:  Louis De Muynck; Philip Van Damme
Journal:  J Mol Neurosci       Date:  2011-05-25       Impact factor: 3.444

Review 4.  Progranulin and its biological effects in cancer.

Authors:  Fabian Arechavaleta-Velasco; Carlos Eduardo Perez-Juarez; George L Gerton; Laura Diaz-Cueto
Journal:  Med Oncol       Date:  2017-11-07       Impact factor: 3.064

5.  Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways.

Authors:  Dong Yang; Lin-Lin Wang; Tao-Tao Dong; Yi-Hang Shen; Xiao-Sun Guo; Chuan-Yong Liu; Jie Liu; Pei Zhang; Juan Li; Yu-Ping Sun
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

6.  Evaluation of tumor metastasis-associated markers for molecular classification in patients with esophageal squamous cell carcinoma.

Authors:  Jun-Xing Huang; Juan Yao; Mao-Song Lin; Mei Lin; Wei Xiao; Hong Yu; Ping Chen; Rong-Yu Qian
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Progranulin: a novel regulator of gastrointestinal cancer progression.

Authors:  Sharon Demorrow
Journal:  Transl Gastrointest Cancer       Date:  2013-07

8.  Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma.

Authors:  Mehran Gholamin; Omeed Moaven; Bahram Memar; Moein Farshchian; Hossein Naseh; Reza Malekzadeh; Masoud Sotoudeh; Mohammad Taghi Rajabi-Mashhadi; Mohammad Naser Forghani; Farid Farrokhi; Mohammad Reza Abbaszadegan
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

9.  Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment.

Authors:  Ramouna Voshtani; Mei Song; Huan Wang; Xiaoqi Li; Wei Zhang; Mojdeh S Tavallaie; Wenjun Yan; Joseph Sun; Fang Wei; Xiaojing Ma
Journal:  Cancer Lett       Date:  2019-09-03       Impact factor: 8.679

10.  Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.

Authors:  Xiaolai Zhou; Thomas Kukar; Rosa Rademakers
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.